Rheumatoid Arthritis Clinical Trials in New York

Showing 1581-1600 of 1,972 trials

Sunnaas International Network´s Stroke Study

NCT01732679

A descriptive study of the stroke rehabilitation content in specialized clinics in seven countries: procedures for admission to rehabilitation, services available and provided to patients, as well as duration of the stay and discharge routines. An observational study of changes in regard to the physical function, quality of life and psycho-social factors in stroke patients before and after specialized rehabilitation

Cerebral Stroke

Sunnaas Rehabilitation Hospital230 participantsStarted Sep 2012

New York, New York, United States • Chengdu, Sichuan, China • Beijing, China +6 more locations

COMPLETEDPhase 2/3< 1 mile

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

NCT00104299

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis is the most common type of small blood vessel inflammation in adults. ANCA-associated vasculitis includes Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA). Rituximab is a man-made antibody used to treat certain types of cancer. The purpose of this study is to determine the effectiveness of rituximab in treating patients with WG and MPA. Study hypothesis: Rituximab is not inferior to conventional therapy in its ability to induce disease remission by Month 6.

VasculitisWegener's GranulomatosisMicroscopic Polyangiitis

National Institute of Allergy and Infectious Diseases (NIAID)197 participantsStarted Jan 2005

Birmingham, Alabama, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +5 more locations

Sunnaas International Network´s Stroke Study

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Rheumatoid Arthritis Trials in Other Cities

Treating Cancer-Related Fatigue Through Systematic Light Exposure

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults

STIP: Statin Trial for Influenza Patients

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

EUS BD vs ERCP TP for Pancreatic Cancer

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation

Staccato Loxapine in Migraine (Out Patient)

Retrospective Claims Analysis of Hysterectomy After Sterilization

Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer

Phase II Proof of Concept Study in Uncomplicated UTI

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

YouScript IMPACT Registry

Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Other Conditions in New York